Andrew Granada, BSN, RN, OCN, is an accomplished oncology nurse with a diverse clinical background spanning over 16 years. Originally from the Philippines, he immigrated to the United States and began his nursing career in medical-surgical care (2009–2018), where he developed a strong foundation in patient safety and acute care. He then transitioned to the operating room (2018–2021), gaining expertise in perioperative nursing and surgical coordination. In 2021, Mr Granada embraced his passion for oncology and joined the Cancer Infusion Center, where he currently serves as a Nurse Clinician III and Chair of the Nursing Professional Development Council.

Mr Granada is dedicated to advancing evidence-based practice and improving patient outcomes. He has led research initiatives on cryotherapy for chemotherapy-induced peripheral neuropathy and taste alteration studies, earning recognition through the Touchstone Award, Daisy Award, Stronger Together Award, Donna King Innovation Award, and Advocate Illinois Masonic Medical Center 2025 Nurse of the Year. His work has been presented at national conferences, including Magnet, Oncology Nursing Credentialing Corporation (ONCC),  and regional clinical science symposiums.

As an immigrant and advocate for professional growth, Mr Granada brings a unique perspective to nursing leadership and education. His commitment to compassionate care and innovation continues to shape the future of infusion therapy.

Adrienne R. Turri, BSN, RN-BC, OCN, is a highly experienced Certified Medical-Surgical and Oncology Registered Nurse with more than 21 years of clinical expertise in a dynamic, urban hospital setting. She earned her Bachelor of Science in Nursing from the University of Illinois Chicago in 2004 and has since built a distinguished career focused on delivering patient-centered, evidence-based care. Ms Turri currently serves at Advocate Illinois Masonic Medical Center’s Creticos Cancer Center in Chicago, where she provides specialized infusion care for adult and older adult oncology patients, including the administration of chemotherapy, immunotherapy, and targeted therapies. Her role extends beyond clinical excellence—she is a trusted educator for patients and families, ensuring they are informed and empowered throughout their treatment journey.

Ms Turri is widely recognized as a collaborative leader and team-builder, serving as charge nurse and mentoring new oncology nurses to foster professional growth and confidence. Her commitment to research and evidence-based practice is demonstrated through her co-leadership of a study on cold therapy interventions for taxane chemotherapy patients, with findings presented at the Magnet American Nurses Association (ANA) Research Conference (2024) and the Oncology Nursing Society Congress (2025). Her contributions have earned her numerous accolades, including a Daisy Award Honoree in 2016 and 2022. 

Throughout her career, Ms Turri has actively participated in hospital-wide councils and task forces, championing initiatives in falls prevention, chemotherapy safety for staff, and process improvement.  She is currently a co-Investigator in an institutional review board (IRB) taste alteration study. Her professional journey reflects her  dedication to compassionate care, clinical excellence, and advancing the nursing profession through leadership, education, and innovation. Ms Turri believes that every patient interaction is an opportunity to make a meaningful difference—one that honors dignity, fosters hope, and inspires healing.